Virtual screening studies on the HCV NS3 helicase. Identification of a substituted piperazine as new anti-HCV scaffold. Synthesis of different series of novel piperazine-based structures. New inhibitors of the subgenomic HCV replicon 1b genotype identified. Novel inhibitors of the HCV NS3 helicase discovered.